Archives of Pediatric Infectious Diseases

Published by: Kowsar

Candidemia in Children Caused by Uncommon Species of Candida

Arezoo Charsizadeh 1 , Hossein Mirhendi 2 , * , Bahram Nikmanesh 3 , Hamid Eshaghi 4 , Maryam Rahmani 5 , Armin Farhang 2 , Heidar Bakhshi 1 and Koichi Makimura 6
Authors Information
1 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Department of Medical Laboratory Science, School of Allied Medical Sciences, Tehran University of Medical Sciences. Tehran, IR Iran
4 Infectious Disease Research Center of Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
5 Children’s Medical Center, Tehran University of Medical Sciences, Tehran, IR Iran
6 Laboratory of Space and Environmental Medicine, Graduate School of Medicine, Teikyo University, Tokyo, Japan
Article information
  • Archives of Pediatric Infectious Diseases: April 2018, 6 (2); e11895
  • Published Online: March 18, 2018
  • Article Type: Research Article
  • Received: February 5, 2017
  • Revised: August 19, 2017
  • Accepted: February 25, 2018
  • DOI: 10.5812/pedinfect.11895

To Cite: Charsizadeh A, Mirhendi H, Nikmanesh B, Eshaghi H, Rahmani M, et al. Candidemia in Children Caused by Uncommon Species of Candida, Arch Pediatr Infect Dis. 2018 ;6(2):e11895. doi: 10.5812/pedinfect.11895.

Abstract
© 2018, Archives of Pediatric Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis. 1997;24(6):1068-78. [PubMed: 9195059].
  • 2. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133-63. doi: 10.1128/CMR.00029-06. [PubMed: 17223626].
  • 3. Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, et al. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008. PLoS One. 2014;9(7). e101510. doi: 10.1371/journal.pone.0101510. [PubMed: 24991967].
  • 4. Mirhendi H, Makimura K, Khoramizadeh M, Yamaguchi H. A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nihon Ishinkin Gakkai Zasshi. 2006;47(3):225-9. [PubMed: 16940958].
  • 5. Mohammadi R, Mirhendi H, Rezaei-Matehkolaei A, Ghahri M, Shidfar MR, Jalalizand N, et al. Molecular identification and distribution profile of Candida species isolated from Iranian patients. Med Mycol. 2013;51(6):657-63. doi: 10.3109/13693786.2013.770603. [PubMed: 23470036].
  • 6. Mirhendi H, Bruun B, Schonheyder HC, Christensen JJ, Fuursted K, Gahrn-Hansen B, et al. Molecular screening for Candida orthopsilosis and Candida metapsilosis among Danish Candida parapsilosis group blood culture isolates: proposal of a new RFLP profile for differentiation. J Med Microbiol. 2010;59(Pt 4):414-20. doi: 10.1099/jmm.0.017293-0. [PubMed: 20056771].
  • 7. Ahmad S, Khan Z, Asadzadeh M, Theyyathel A, Chandy R. Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis. BMC Infect Dis. 2012;12:230. doi: 10.1186/1471-2334-12-230. [PubMed: 23009343].
  • 8. Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med. 2015;373(15):1445-56. doi: 10.1056/NEJMra1315399. [PubMed: 26444731].
  • 9. Steinbach WJ, Roilides E, Berman D, Hoffman JA, Groll AH, Bin-Hussain I, et al. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J. 2012;31(12):1252-7. doi: 10.1097/INF.0b013e3182737427. [PubMed: 22982980].
  • 10. Downey LC, Smith PB, Benjamin DJ. Risk factors and prevention of late-onset sepsis in premature infants. Early Hum Dev. 2010;86 Suppl 1:7-12. doi: 10.1016/j.earlhumdev.2010.01.012. [PubMed: 20116186].
  • 11. Zaoutis TE, Prasad PA, Localio AR, Coffin SE, Bell LM, Walsh TJ, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis. 2010;51(5):e38-45. doi: 10.1086/655698. [PubMed: 20636126].
  • 12. Baradkar VP, Mathur M, Kumar S, Rathi M. Candida glabrata: Emerging pathogen in neonatal sepsis. AnnTrop Med Public Health. 2008;1(1):5. doi: 10.4103/1755-6783.43070.
  • 13. Neu N, Malik M, Lunding A, Whittier S, Alba L, Kubin C, et al. Epidemiology of candidemia at a Children's hospital, 2002 to 2006. Pediatr Infect Dis J. 2009;28(9):806-9. doi: 10.1097/INF.0b013e3181a0d78d. [PubMed: 19636286].
  • 14. Chakrabarti A. Candida glabrata candidemia. Indian J Crit Care Med. 2015;19(3):138-9. doi: 10.4103/0972-5229.152753. [PubMed: 25810607].
  • 15. Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, et al. Candida spp. with acquired echinocandin resistance, France, 2004-2010. Emerg Infect Dis. 2012;18(1):86-90. doi: 10.3201/eid1801.110556. [PubMed: 22257484].
  • 16. Peman J, Canton E, Linares-Sicilia MJ, Rosello EM, Borrell N, Ruiz-Perez-de-Pipaon MT, et al. Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey. J Clin Microbiol. 2011;49(12):4158-63. doi: 10.1128/JCM.05474-11. [PubMed: 22012014].
  • 17. Ruiz LS, Khouri S, Hahn RC, da Silva EG, de Oliveira VK, Gandra RF, et al. Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility. Mycopathologia. 2013;175(3-4):231-9. doi: 10.1007/s11046-013-9616-5. [PubMed: 23404576].
  • 18. Oliveira VK, Paula CR, Colombo AL, Merseguel KB, Nishikaku AS, Moreira D, et al. Candidemia and death by Candida orthopsilosis and Candida metapsilosis in neonates and children. Pediatr Neonatol. 2014;55(1):75-6. doi: 10.1016/j.pedneo.2013.07.006. [PubMed: 24113226].
  • 19. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol. 2008;46(8):2659-64. doi: 10.1128/JCM.00803-08. [PubMed: 18562582].
  • 20. Bertini A, De Bernardis F, Hensgens LA, Sandini S, Senesi S, Tavanti A. Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity. Int J Med Microbiol. 2013;303(2):98-103. doi: 10.1016/j.ijmm.2012.12.006. [PubMed: 23403338].
  • 21. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48(12):1695-703. doi: 10.1086/599039. [PubMed: 19441981].
  • 22. Atkinson BJ, Lewis RE, Kontoyiannis DP. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol. 2008;46(6):541-6. doi: 10.1080/13693780801968571. [PubMed: 19180749].
  • 23. Diekema DJ, Messer SA, Boyken LB, Hollis RJ, Kroeger J, Tendolkar S, et al. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol. 2009;47(10):3170-7. doi: 10.1128/JCM.00942-09. [PubMed: 19710283].
  • 24. Sendid B, Lacroix C, Bougnoux ME. Is Candida kefyr an emerging pathogen in patients with oncohematological diseases?. Clin Infect Dis. 2006;43(5):666-7. doi: 10.1086/506573. [PubMed: 16886166].
  • 25. Khan Z, Ahmad S, Al-Obaid K, Joseph L, Chandy R. Candida kefyr as a cause of bloodstream infection and adjunctive role of biomarkers in its diagnosis. J Mycol Med. 2015;25(1):71-5. doi: 10.1016/j.mycmed.2014.04.002. [PubMed: 25442911].
  • 26. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, et al. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol. 2008;46(1):150-6. doi: 10.1128/JCM.01901-07. [PubMed: 18032613].
  • 27. Fekkar A, Meyer I, Brossas JY, Dannaoui E, Palous M, Uzunov M, et al. Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin. Antimicrob Agents Chemother. 2013;57(5):2380-2. doi: 10.1128/AAC.02037-12. [PubMed: 23439642].
  • 28. Ruan SY, Chien JY, Hou YC, Hsueh PR. Catheter-related fungemia caused by Candida intermedia. Int J Infect Dis. 2010;14(2):e147-9. doi: 10.1016/j.ijid.2009.03.015. [PubMed: 19497773].
  • 29. Steinbach WJ. Pediatric Invasive Candidiasis: Epidemiology and Diagnosis in Children. J Fungi (Basel). 2016;2(1). doi: 10.3390/jof2010005. [PubMed: 29376923].
  • 30. Dutta A, Palazzi DL. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J. 2011;30(8):664-8. doi: 10.1097/INF.0b013e318213da0f. [PubMed: 21372750].
  • 31. Charsizadeh A, Mirhendi H, Nikmanesh B, Eshaghi H, Makimura K. Microbial epidemiology of candidaemia in neonatal and paediatric intensive care units at the Children's Medical Center, Tehran. Mycoses. 2018 1;61(1):22-9. doi: 10.1111/myc.12698. [PubMed: 28872714].

Altmetric:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Comments